nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—psoriasis—skin cancer	0.737	1	CtDrD
Calcitriol—CYP3A4—Temozolomide—skin cancer	0.0415	0.292	CbGbCtD
Calcitriol—CYP3A4—Imiquimod—skin cancer	0.0415	0.292	CbGbCtD
Calcitriol—CYP3A4—Vismodegib—skin cancer	0.0287	0.202	CbGbCtD
Calcitriol—CYP3A4—Vemurafenib—skin cancer	0.0227	0.16	CbGbCtD
Calcitriol—CYP3A4—Docetaxel—skin cancer	0.00779	0.0548	CbGbCtD
Calcitriol—VDR—leg—skin cancer	0.00601	0.13	CbGeAlD
Calcitriol—VDR—forelimb—skin cancer	0.00596	0.129	CbGeAlD
Calcitriol—VDR—hindlimb—skin cancer	0.00537	0.116	CbGeAlD
Calcitriol—VDR—appendage—skin cancer	0.0046	0.0994	CbGeAlD
Calcitriol—VDR—skin epidermis—skin cancer	0.00383	0.0827	CbGeAlD
Calcitriol—VDR—hair follicle—skin cancer	0.00273	0.059	CbGeAlD
Calcitriol—GC—lymphoid tissue—skin cancer	0.00209	0.0452	CbGeAlD
Calcitriol—GC—female reproductive system—skin cancer	0.00202	0.0436	CbGeAlD
Calcitriol—Neoplasm malignant—Vismodegib—skin cancer	0.00192	0.0257	CcSEcCtD
Calcitriol—VDR—nipple—skin cancer	0.00185	0.04	CbGeAlD
Calcitriol—VDR—neck—skin cancer	0.00183	0.0396	CbGeAlD
Calcitriol—CYP24A1—female reproductive system—skin cancer	0.00168	0.0363	CbGeAlD
Calcitriol—Sensory disturbance—Temozolomide—skin cancer	0.00167	0.0224	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Vismodegib—skin cancer	0.00164	0.022	CcSEcCtD
Calcitriol—Blood urea increased—Vismodegib—skin cancer	0.00155	0.0208	CcSEcCtD
Calcitriol—Psoriasis—Imiquimod—skin cancer	0.00138	0.0184	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Vismodegib—skin cancer	0.00137	0.0183	CcSEcCtD
Calcitriol—VDR—connective tissue—skin cancer	0.00131	0.0284	CbGeAlD
Calcitriol—VDR—epithelium—skin cancer	0.00125	0.0269	CbGeAlD
Calcitriol—Pain in extremity—Vismodegib—skin cancer	0.00119	0.016	CcSEcCtD
Calcitriol—Neoplasm malignant—Vemurafenib—skin cancer	0.00119	0.0159	CcSEcCtD
Calcitriol—VDR—skin of body—skin cancer	0.00119	0.0256	CbGeAlD
Calcitriol—Dehydration—Vismodegib—skin cancer	0.00111	0.0148	CcSEcCtD
Calcitriol—Abdominal pain upper—Vismodegib—skin cancer	0.00109	0.0146	CcSEcCtD
Calcitriol—VDR—mammalian vulva—skin cancer	0.00108	0.0234	CbGeAlD
Calcitriol—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00107	0.0144	CcSEcCtD
Calcitriol—VDR—lymphoid tissue—skin cancer	0.00096	0.0207	CbGeAlD
Calcitriol—Weight decreased—Vismodegib—skin cancer	0.000932	0.0125	CcSEcCtD
Calcitriol—VDR—female reproductive system—skin cancer	0.000926	0.02	CbGeAlD
Calcitriol—Hypercholesterolaemia—Imiquimod—skin cancer	0.000914	0.0122	CcSEcCtD
Calcitriol—Bone pain—Imiquimod—skin cancer	0.000903	0.0121	CcSEcCtD
Calcitriol—VDR—head—skin cancer	0.000774	0.0167	CbGeAlD
Calcitriol—Pain in extremity—Vemurafenib—skin cancer	0.000736	0.00986	CcSEcCtD
Calcitriol—Apathy—Temozolomide—skin cancer	0.000726	0.00972	CcSEcCtD
Calcitriol—Flat affect—Temozolomide—skin cancer	0.000719	0.00963	CcSEcCtD
Calcitriol—Dysgeusia—Vismodegib—skin cancer	0.000703	0.00941	CcSEcCtD
Calcitriol—Blister—Fluorouracil—skin cancer	0.000663	0.00887	CcSEcCtD
Calcitriol—Pain in extremity—Imiquimod—skin cancer	0.000628	0.00841	CcSEcCtD
Calcitriol—Myalgia—Vismodegib—skin cancer	0.000611	0.00818	CcSEcCtD
Calcitriol—Weight decreased—Vemurafenib—skin cancer	0.000576	0.00771	CcSEcCtD
Calcitriol—Skin disorder—Vismodegib—skin cancer	0.000569	0.00762	CcSEcCtD
Calcitriol—VDR—lymph node—skin cancer	0.000542	0.0117	CbGeAlD
Calcitriol—Musculoskeletal discomfort—Vismodegib—skin cancer	0.000534	0.00714	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Temozolomide—skin cancer	0.000518	0.00694	CcSEcCtD
Calcitriol—Redness—Docetaxel—skin cancer	0.000511	0.00684	CcSEcCtD
Calcitriol—Decreased appetite—Vismodegib—skin cancer	0.000509	0.00682	CcSEcCtD
Calcitriol—Constipation—Vismodegib—skin cancer	0.000501	0.00671	CcSEcCtD
Calcitriol—Pain—Vismodegib—skin cancer	0.000501	0.00671	CcSEcCtD
Calcitriol—Erythema multiforme—Vemurafenib—skin cancer	0.000482	0.00645	CcSEcCtD
Calcitriol—Gastrointestinal pain—Vismodegib—skin cancer	0.000479	0.00641	CcSEcCtD
Calcitriol—Conjunctivitis—Imiquimod—skin cancer	0.00047	0.0063	CcSEcCtD
Calcitriol—Urinary tract infection—Imiquimod—skin cancer	0.00047	0.0063	CcSEcCtD
Calcitriol—Abdominal pain—Vismodegib—skin cancer	0.000463	0.0062	CcSEcCtD
Calcitriol—Photophobia—Fluorouracil—skin cancer	0.000448	0.006	CcSEcCtD
Calcitriol—Erythema—Vemurafenib—skin cancer	0.000443	0.00594	CcSEcCtD
Calcitriol—Haemoglobin—Imiquimod—skin cancer	0.000437	0.00584	CcSEcCtD
Calcitriol—Haemorrhage—Imiquimod—skin cancer	0.000434	0.00582	CcSEcCtD
Calcitriol—Dysgeusia—Vemurafenib—skin cancer	0.000434	0.00581	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Temozolomide—skin cancer	0.000433	0.00579	CcSEcCtD
Calcitriol—Rhinorrhoea—Docetaxel—skin cancer	0.000425	0.0057	CcSEcCtD
Calcitriol—Asthenia—Vismodegib—skin cancer	0.00042	0.00563	CcSEcCtD
Calcitriol—Pruritus—Vismodegib—skin cancer	0.000414	0.00555	CcSEcCtD
Calcitriol—Erythema multiforme—Imiquimod—skin cancer	0.000411	0.0055	CcSEcCtD
Calcitriol—Diarrhoea—Vismodegib—skin cancer	0.000401	0.00537	CcSEcCtD
Calcitriol—Thirst—Temozolomide—skin cancer	0.000395	0.00529	CcSEcCtD
Calcitriol—Arrhythmia—Imiquimod—skin cancer	0.000388	0.00519	CcSEcCtD
Calcitriol—Erythema—Imiquimod—skin cancer	0.000378	0.00506	CcSEcCtD
Calcitriol—Myalgia—Vemurafenib—skin cancer	0.000377	0.00505	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.000375	0.00502	CcSEcCtD
Calcitriol—Vomiting—Vismodegib—skin cancer	0.000372	0.00499	CcSEcCtD
Calcitriol—Rash—Vismodegib—skin cancer	0.000369	0.00494	CcSEcCtD
Calcitriol—Dermatitis—Vismodegib—skin cancer	0.000369	0.00494	CcSEcCtD
Calcitriol—Dermatitis bullous—Fluorouracil—skin cancer	0.000363	0.00486	CcSEcCtD
Calcitriol—Anaphylactic shock—Vemurafenib—skin cancer	0.000362	0.00484	CcSEcCtD
Calcitriol—Bone pain—Docetaxel—skin cancer	0.00036	0.00482	CcSEcCtD
Calcitriol—Skin disorder—Vemurafenib—skin cancer	0.000351	0.00471	CcSEcCtD
Calcitriol—Dehydration—Temozolomide—skin cancer	0.00035	0.00468	CcSEcCtD
Calcitriol—Weight decreased—Bleomycin—skin cancer	0.000349	0.00467	CcSEcCtD
Calcitriol—Nausea—Vismodegib—skin cancer	0.000348	0.00466	CcSEcCtD
Calcitriol—Agitation—Imiquimod—skin cancer	0.000347	0.00465	CcSEcCtD
Calcitriol—Phosphatase alkaline increased—Docetaxel—skin cancer	0.000345	0.00462	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.000339	0.00454	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00033	0.00441	CcSEcCtD
Calcitriol—Convulsion—Imiquimod—skin cancer	0.000328	0.00439	CcSEcCtD
Calcitriol—Hypertension—Imiquimod—skin cancer	0.000326	0.00437	CcSEcCtD
Calcitriol—Chest pain—Imiquimod—skin cancer	0.000322	0.00431	CcSEcCtD
Calcitriol—Myalgia—Imiquimod—skin cancer	0.000322	0.00431	CcSEcCtD
Calcitriol—Anxiety—Imiquimod—skin cancer	0.000321	0.00429	CcSEcCtD
Calcitriol—Discomfort—Imiquimod—skin cancer	0.000318	0.00426	CcSEcCtD
Calcitriol—Dry mouth—Imiquimod—skin cancer	0.000315	0.00421	CcSEcCtD
Calcitriol—Decreased appetite—Vemurafenib—skin cancer	0.000315	0.00421	CcSEcCtD
Calcitriol—Haemoglobin—Bleomycin—skin cancer	0.00031	0.00415	CcSEcCtD
Calcitriol—Nasopharyngitis—Fluorouracil—skin cancer	0.00031	0.00415	CcSEcCtD
Calcitriol—CYP3A4—female reproductive system—skin cancer	0.00031	0.00669	CbGeAlD
Calcitriol—Constipation—Vemurafenib—skin cancer	0.000309	0.00414	CcSEcCtD
Calcitriol—Haemorrhage—Bleomycin—skin cancer	0.000309	0.00413	CcSEcCtD
Calcitriol—Skin disorder—Imiquimod—skin cancer	0.0003	0.00401	CcSEcCtD
Calcitriol—Weight decreased—Temozolomide—skin cancer	0.000294	0.00394	CcSEcCtD
Calcitriol—Anorexia—Imiquimod—skin cancer	0.000294	0.00394	CcSEcCtD
Calcitriol—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000288	0.00385	CcSEcCtD
Calcitriol—Body temperature increased—Vemurafenib—skin cancer	0.000286	0.00383	CcSEcCtD
Calcitriol—Urinary tract infection—Temozolomide—skin cancer	0.000282	0.00377	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000281	0.00376	CcSEcCtD
Calcitriol—Insomnia—Imiquimod—skin cancer	0.000279	0.00374	CcSEcCtD
Calcitriol—Somnolence—Imiquimod—skin cancer	0.000274	0.00367	CcSEcCtD
Calcitriol—Erythema multiforme—Dactinomycin—skin cancer	0.000272	0.00364	CcSEcCtD
Calcitriol—Erythema—Bleomycin—skin cancer	0.000269	0.0036	CcSEcCtD
Calcitriol—Decreased appetite—Imiquimod—skin cancer	0.000268	0.00359	CcSEcCtD
Calcitriol—Hypersensitivity—Vemurafenib—skin cancer	0.000267	0.00357	CcSEcCtD
Calcitriol—Pain—Imiquimod—skin cancer	0.000264	0.00353	CcSEcCtD
Calcitriol—Dermatitis bullous—Docetaxel—skin cancer	0.000262	0.00351	CcSEcCtD
Calcitriol—Haemoglobin—Temozolomide—skin cancer	0.000262	0.0035	CcSEcCtD
Calcitriol—Haemorrhage—Temozolomide—skin cancer	0.00026	0.00348	CcSEcCtD
Calcitriol—Urinary tract infection—Fluorouracil—skin cancer	0.00026	0.00348	CcSEcCtD
Calcitriol—Conjunctivitis—Fluorouracil—skin cancer	0.00026	0.00348	CcSEcCtD
Calcitriol—Asthenia—Vemurafenib—skin cancer	0.00026	0.00348	CcSEcCtD
Calcitriol—Pruritus—Vemurafenib—skin cancer	0.000256	0.00343	CcSEcCtD
Calcitriol—Gastrointestinal pain—Imiquimod—skin cancer	0.000252	0.00338	CcSEcCtD
Calcitriol—Erythema—Dactinomycin—skin cancer	0.000251	0.00335	CcSEcCtD
Calcitriol—Pain in extremity—Docetaxel—skin cancer	0.00025	0.00335	CcSEcCtD
Calcitriol—Diarrhoea—Vemurafenib—skin cancer	0.000248	0.00331	CcSEcCtD
Calcitriol—Erythema multiforme—Temozolomide—skin cancer	0.000246	0.00329	CcSEcCtD
Calcitriol—Urticaria—Imiquimod—skin cancer	0.000245	0.00328	CcSEcCtD
Calcitriol—Abdominal pain—Imiquimod—skin cancer	0.000244	0.00327	CcSEcCtD
Calcitriol—Body temperature increased—Imiquimod—skin cancer	0.000244	0.00327	CcSEcCtD
Calcitriol—Haemoglobin—Fluorouracil—skin cancer	0.000241	0.00323	CcSEcCtD
Calcitriol—Haemorrhage—Fluorouracil—skin cancer	0.00024	0.00321	CcSEcCtD
Calcitriol—Dehydration—Docetaxel—skin cancer	0.000233	0.00312	CcSEcCtD
Calcitriol—Vomiting—Vemurafenib—skin cancer	0.00023	0.00308	CcSEcCtD
Calcitriol—Chest pain—Bleomycin—skin cancer	0.000229	0.00306	CcSEcCtD
Calcitriol—Myalgia—Bleomycin—skin cancer	0.000229	0.00306	CcSEcCtD
Calcitriol—Abdominal pain upper—Docetaxel—skin cancer	0.000229	0.00306	CcSEcCtD
Calcitriol—Rash—Vemurafenib—skin cancer	0.000228	0.00305	CcSEcCtD
Calcitriol—Dermatitis—Vemurafenib—skin cancer	0.000228	0.00305	CcSEcCtD
Calcitriol—Hypersensitivity—Imiquimod—skin cancer	0.000227	0.00304	CcSEcCtD
Calcitriol—Headache—Vemurafenib—skin cancer	0.000227	0.00303	CcSEcCtD
Calcitriol—Erythema—Temozolomide—skin cancer	0.000227	0.00303	CcSEcCtD
Calcitriol—Discomfort—Bleomycin—skin cancer	0.000226	0.00303	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000225	0.00302	CcSEcCtD
Calcitriol—Nasopharyngitis—Docetaxel—skin cancer	0.000224	0.003	CcSEcCtD
Calcitriol—Dysgeusia—Temozolomide—skin cancer	0.000222	0.00297	CcSEcCtD
Calcitriol—Asthenia—Imiquimod—skin cancer	0.000221	0.00296	CcSEcCtD
Calcitriol—Anaphylactic shock—Bleomycin—skin cancer	0.000219	0.00294	CcSEcCtD
Calcitriol—Pruritus—Imiquimod—skin cancer	0.000218	0.00292	CcSEcCtD
Calcitriol—Nausea—Vemurafenib—skin cancer	0.000215	0.00288	CcSEcCtD
Calcitriol—Arrhythmia—Fluorouracil—skin cancer	0.000214	0.00287	CcSEcCtD
Calcitriol—Myalgia—Dactinomycin—skin cancer	0.000213	0.00286	CcSEcCtD
Calcitriol—Diarrhoea—Imiquimod—skin cancer	0.000211	0.00283	CcSEcCtD
Calcitriol—Discomfort—Dactinomycin—skin cancer	0.000211	0.00282	CcSEcCtD
Calcitriol—Anorexia—Bleomycin—skin cancer	0.000209	0.0028	CcSEcCtD
Calcitriol—Erythema—Fluorouracil—skin cancer	0.000209	0.0028	CcSEcCtD
Calcitriol—Agitation—Temozolomide—skin cancer	0.000208	0.00279	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.0002	0.00267	CcSEcCtD
Calcitriol—Convulsion—Temozolomide—skin cancer	0.000196	0.00263	CcSEcCtD
Calcitriol—Vomiting—Imiquimod—skin cancer	0.000196	0.00263	CcSEcCtD
Calcitriol—Weight decreased—Docetaxel—skin cancer	0.000196	0.00262	CcSEcCtD
Calcitriol—Hypertension—Temozolomide—skin cancer	0.000196	0.00262	CcSEcCtD
Calcitriol—Anorexia—Dactinomycin—skin cancer	0.000195	0.00261	CcSEcCtD
Calcitriol—Rash—Imiquimod—skin cancer	0.000195	0.0026	CcSEcCtD
Calcitriol—Dermatitis—Imiquimod—skin cancer	0.000194	0.0026	CcSEcCtD
Calcitriol—Headache—Imiquimod—skin cancer	0.000193	0.00259	CcSEcCtD
Calcitriol—Myalgia—Temozolomide—skin cancer	0.000193	0.00258	CcSEcCtD
Calcitriol—Anxiety—Temozolomide—skin cancer	0.000192	0.00257	CcSEcCtD
Calcitriol—Discomfort—Temozolomide—skin cancer	0.000191	0.00255	CcSEcCtD
Calcitriol—Decreased appetite—Bleomycin—skin cancer	0.000191	0.00255	CcSEcCtD
Calcitriol—Dry mouth—Temozolomide—skin cancer	0.000189	0.00253	CcSEcCtD
Calcitriol—Pain—Bleomycin—skin cancer	0.000187	0.00251	CcSEcCtD
Calcitriol—Conjunctivitis—Docetaxel—skin cancer	0.000187	0.00251	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000186	0.00249	CcSEcCtD
Calcitriol—Anaphylactic shock—Temozolomide—skin cancer	0.000185	0.00248	CcSEcCtD
Calcitriol—Nausea—Imiquimod—skin cancer	0.000183	0.00245	CcSEcCtD
Calcitriol—Convulsion—Fluorouracil—skin cancer	0.000181	0.00242	CcSEcCtD
Calcitriol—Skin disorder—Temozolomide—skin cancer	0.00018	0.0024	CcSEcCtD
Calcitriol—Chest pain—Fluorouracil—skin cancer	0.000178	0.00238	CcSEcCtD
Calcitriol—Myalgia—Fluorouracil—skin cancer	0.000178	0.00238	CcSEcCtD
Calcitriol—Decreased appetite—Dactinomycin—skin cancer	0.000178	0.00238	CcSEcCtD
Calcitriol—Anorexia—Temozolomide—skin cancer	0.000176	0.00236	CcSEcCtD
Calcitriol—Discomfort—Fluorouracil—skin cancer	0.000176	0.00235	CcSEcCtD
Calcitriol—Pain—Dactinomycin—skin cancer	0.000175	0.00234	CcSEcCtD
Calcitriol—Urticaria—Bleomycin—skin cancer	0.000174	0.00233	CcSEcCtD
Calcitriol—Haemoglobin—Docetaxel—skin cancer	0.000174	0.00233	CcSEcCtD
Calcitriol—Body temperature increased—Bleomycin—skin cancer	0.000173	0.00232	CcSEcCtD
Calcitriol—Haemorrhage—Docetaxel—skin cancer	0.000173	0.00232	CcSEcCtD
Calcitriol—Anaphylactic shock—Fluorouracil—skin cancer	0.00017	0.00228	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000168	0.00226	CcSEcCtD
Calcitriol—Insomnia—Temozolomide—skin cancer	0.000167	0.00224	CcSEcCtD
Calcitriol—Gastrointestinal pain—Dactinomycin—skin cancer	0.000167	0.00224	CcSEcCtD
Calcitriol—Somnolence—Temozolomide—skin cancer	0.000164	0.0022	CcSEcCtD
Calcitriol—Erythema multiforme—Docetaxel—skin cancer	0.000164	0.00219	CcSEcCtD
Calcitriol—Anorexia—Fluorouracil—skin cancer	0.000162	0.00217	CcSEcCtD
Calcitriol—Abdominal pain—Dactinomycin—skin cancer	0.000162	0.00216	CcSEcCtD
Calcitriol—Body temperature increased—Dactinomycin—skin cancer	0.000162	0.00216	CcSEcCtD
Calcitriol—Hypersensitivity—Bleomycin—skin cancer	0.000162	0.00216	CcSEcCtD
Calcitriol—Decreased appetite—Temozolomide—skin cancer	0.000161	0.00215	CcSEcCtD
Calcitriol—Constipation—Temozolomide—skin cancer	0.000158	0.00212	CcSEcCtD
Calcitriol—Pain—Temozolomide—skin cancer	0.000158	0.00212	CcSEcCtD
Calcitriol—Asthenia—Bleomycin—skin cancer	0.000157	0.00211	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000155	0.00208	CcSEcCtD
Calcitriol—Pruritus—Bleomycin—skin cancer	0.000155	0.00208	CcSEcCtD
Calcitriol—Arrhythmia—Docetaxel—skin cancer	0.000155	0.00207	CcSEcCtD
Calcitriol—Insomnia—Fluorouracil—skin cancer	0.000154	0.00206	CcSEcCtD
Calcitriol—Somnolence—Fluorouracil—skin cancer	0.000151	0.00203	CcSEcCtD
Calcitriol—Gastrointestinal pain—Temozolomide—skin cancer	0.000151	0.00202	CcSEcCtD
Calcitriol—Erythema—Docetaxel—skin cancer	0.000151	0.00202	CcSEcCtD
Calcitriol—Hypersensitivity—Dactinomycin—skin cancer	0.000151	0.00202	CcSEcCtD
Calcitriol—Decreased appetite—Fluorouracil—skin cancer	0.000148	0.00198	CcSEcCtD
Calcitriol—Dysgeusia—Docetaxel—skin cancer	0.000148	0.00198	CcSEcCtD
Calcitriol—Urticaria—Temozolomide—skin cancer	0.000147	0.00197	CcSEcCtD
Calcitriol—Asthenia—Dactinomycin—skin cancer	0.000147	0.00196	CcSEcCtD
Calcitriol—Body temperature increased—Temozolomide—skin cancer	0.000146	0.00196	CcSEcCtD
Calcitriol—Abdominal pain—Temozolomide—skin cancer	0.000146	0.00196	CcSEcCtD
Calcitriol—Pain—Fluorouracil—skin cancer	0.000146	0.00195	CcSEcCtD
Calcitriol—Diarrhoea—Dactinomycin—skin cancer	0.00014	0.00187	CcSEcCtD
Calcitriol—Vomiting—Bleomycin—skin cancer	0.000139	0.00187	CcSEcCtD
Calcitriol—Rash—Bleomycin—skin cancer	0.000138	0.00185	CcSEcCtD
Calcitriol—Dermatitis—Bleomycin—skin cancer	0.000138	0.00185	CcSEcCtD
Calcitriol—Hypersensitivity—Temozolomide—skin cancer	0.000136	0.00182	CcSEcCtD
Calcitriol—Urticaria—Fluorouracil—skin cancer	0.000135	0.00181	CcSEcCtD
Calcitriol—Body temperature increased—Fluorouracil—skin cancer	0.000135	0.0018	CcSEcCtD
Calcitriol—Asthenia—Temozolomide—skin cancer	0.000133	0.00178	CcSEcCtD
Calcitriol—Pruritus—Temozolomide—skin cancer	0.000131	0.00175	CcSEcCtD
Calcitriol—Convulsion—Docetaxel—skin cancer	0.000131	0.00175	CcSEcCtD
Calcitriol—Nausea—Bleomycin—skin cancer	0.00013	0.00174	CcSEcCtD
Calcitriol—Hypertension—Docetaxel—skin cancer	0.00013	0.00174	CcSEcCtD
Calcitriol—Vomiting—Dactinomycin—skin cancer	0.00013	0.00174	CcSEcCtD
Calcitriol—Rash—Dactinomycin—skin cancer	0.000129	0.00173	CcSEcCtD
Calcitriol—Chest pain—Docetaxel—skin cancer	0.000128	0.00172	CcSEcCtD
Calcitriol—Myalgia—Docetaxel—skin cancer	0.000128	0.00172	CcSEcCtD
Calcitriol—Diarrhoea—Temozolomide—skin cancer	0.000127	0.00169	CcSEcCtD
Calcitriol—Hypersensitivity—Fluorouracil—skin cancer	0.000126	0.00168	CcSEcCtD
Calcitriol—Dry mouth—Docetaxel—skin cancer	0.000125	0.00168	CcSEcCtD
Calcitriol—Anaphylactic shock—Docetaxel—skin cancer	0.000123	0.00165	CcSEcCtD
Calcitriol—Nausea—Dactinomycin—skin cancer	0.000121	0.00163	CcSEcCtD
Calcitriol—Pruritus—Fluorouracil—skin cancer	0.000121	0.00161	CcSEcCtD
Calcitriol—Skin disorder—Docetaxel—skin cancer	0.000119	0.0016	CcSEcCtD
Calcitriol—Vomiting—Temozolomide—skin cancer	0.000118	0.00157	CcSEcCtD
Calcitriol—Anorexia—Docetaxel—skin cancer	0.000117	0.00157	CcSEcCtD
Calcitriol—Rash—Temozolomide—skin cancer	0.000117	0.00156	CcSEcCtD
Calcitriol—Diarrhoea—Fluorouracil—skin cancer	0.000117	0.00156	CcSEcCtD
Calcitriol—Dermatitis—Temozolomide—skin cancer	0.000116	0.00156	CcSEcCtD
Calcitriol—Headache—Temozolomide—skin cancer	0.000116	0.00155	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000112	0.0015	CcSEcCtD
Calcitriol—Insomnia—Docetaxel—skin cancer	0.000111	0.00149	CcSEcCtD
Calcitriol—Nausea—Temozolomide—skin cancer	0.00011	0.00147	CcSEcCtD
Calcitriol—Somnolence—Docetaxel—skin cancer	0.000109	0.00146	CcSEcCtD
Calcitriol—Vomiting—Fluorouracil—skin cancer	0.000108	0.00145	CcSEcCtD
Calcitriol—Rash—Fluorouracil—skin cancer	0.000107	0.00144	CcSEcCtD
Calcitriol—Dermatitis—Fluorouracil—skin cancer	0.000107	0.00144	CcSEcCtD
Calcitriol—Decreased appetite—Docetaxel—skin cancer	0.000107	0.00143	CcSEcCtD
Calcitriol—Headache—Fluorouracil—skin cancer	0.000107	0.00143	CcSEcCtD
Calcitriol—Pain—Docetaxel—skin cancer	0.000105	0.00141	CcSEcCtD
Calcitriol—Constipation—Docetaxel—skin cancer	0.000105	0.00141	CcSEcCtD
Calcitriol—Nausea—Fluorouracil—skin cancer	0.000101	0.00136	CcSEcCtD
Calcitriol—Gastrointestinal pain—Docetaxel—skin cancer	0.000101	0.00135	CcSEcCtD
Calcitriol—Abdominal pain—Docetaxel—skin cancer	9.72e-05	0.0013	CcSEcCtD
Calcitriol—Body temperature increased—Docetaxel—skin cancer	9.72e-05	0.0013	CcSEcCtD
Calcitriol—Hypersensitivity—Docetaxel—skin cancer	9.06e-05	0.00121	CcSEcCtD
Calcitriol—Asthenia—Docetaxel—skin cancer	8.82e-05	0.00118	CcSEcCtD
Calcitriol—Pruritus—Docetaxel—skin cancer	8.7e-05	0.00116	CcSEcCtD
Calcitriol—Diarrhoea—Docetaxel—skin cancer	8.41e-05	0.00113	CcSEcCtD
Calcitriol—Vomiting—Docetaxel—skin cancer	7.82e-05	0.00105	CcSEcCtD
Calcitriol—Rash—Docetaxel—skin cancer	7.75e-05	0.00104	CcSEcCtD
Calcitriol—Dermatitis—Docetaxel—skin cancer	7.75e-05	0.00104	CcSEcCtD
Calcitriol—Headache—Docetaxel—skin cancer	7.7e-05	0.00103	CcSEcCtD
Calcitriol—Nausea—Docetaxel—skin cancer	7.3e-05	0.000978	CcSEcCtD
